Conducting Clinical Trials in the Parallel Virtual Universe

Capture new insights into accelerating and streamlining processes at every stage of clinical research. Don’t miss this illuminating article from Certara.

Read now for insights into:

Using virtual trials to inform concurrently running real-world trials
Designing and running virtual trials for maximum realism
Investigating drug combinations via virtual trials
Determining the likelihood of drug-drug interactions (DDIs) via virtual trials
Using virtual trials to investigate scenarios impossible to test in real-world clinical studies

Read the Article

Your company email address

Please select your industry: (max 1)

Opt In?

Berne Media may store and process my information. For details, see the Privacy Notice.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
By clicking submit, you consent to allow Certara to store and process the information submitted to provide you the content requested. They are subject to Certara's Terms and Conditions.

Maximizing value across drug development: Embracing a new CDMO and CRO partnership approach

In this webinar, we will present key insights from preliminary findings by the TUFTS Center for the Study of Drug Development, exploring how a comprehensive model that brings CDMO and CRO services under one roof can significantly impact the expected Net Present Value (eNPV) of drug development programs. We will demonstrate how streamlined services across drug substance, drug product, and clinical research can enhance efficiency, reduce timelines, and ultimately deliver high-quality therapies to patients faster. Key takeaways include:

Conducting Clinical Trials in the Parallel Virtual Universe

Read the Article

Opt In?

Explore similar content

Safety & Regulatory Compliance Predictions For 2025

Maximizing value across drug development: Embracing a new CDMO and CRO partnership approach

Getting The Most Out Of Your Lab Space